However, vitamin D receptor activation in cancer-associated fibroblasts can eliminate CAF-derived IL-8 mediated GC oxaliplatin resistance in GC by blocking PI3K/Akt signaling, which provides a promising basis for overcoming GC drug resistance in clinical practice (82). Here, AKT1 is linked to gastric cancer.